MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK) has a MoatMap StockRank of 55/100 based on Quality (57/100), Value (28/100), and Momentum (55/100) factor scores. The current signal is HOLD. MicroTech Medical focuses on diabetes patch pumps. It operates in a highly competitive medical device niche without clear alignment to our core macro themes of energy, advanced packaging, or supply chain localization.
MicroTech Medical (Hangzhou) Co., Ltd. specializes in diabetes management medical devices, including continuous glucose monitoring (CGM) systems and patch insulin pumps. The company provides integrated solutions that combine hardware devices with cloud-based digital health management platforms. Its competitive moat is established through proprietary sensor technology and regulatory approvals in both China and Europe.
| Price | $0.94 |
| Market Cap | $385M |
| P/E (TTM) | 60.83 |
| P/E (Forward) | 15.57 |
| Price/Book | 1.31 |
| Return on Equity | 2.0% |
| Return on Invested Capital | 2.0% |
| Debt/Equity | 3.22 |
| Gross Margin | 52.7% |
| Operating Margin | 4.4% |
| Revenue Growth | 113.0% |
| Free Cash Flow | $-534K |
MicroTech Medical (Hangzhou) Co., Ltd. operates in the Medical Devices industry, part of the Healthcare sector (China).